GWPH
GW Pharmaceuticals plc
Set alert
— — —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 6.81B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 44.50
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 30, 2021
- 50-d avg
- 218.22
- 200-d avg
- 167.56
- 1y target
- 201.13
Key statistics
- Market cap
- 6.81B
- Trailing P/E
- 0.00
- Forward P/E
- 44.50
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 218.22
- 200-day average
- 167.56
Analyst view
Consensus: hold
Hold
Price target (mean) 201.13
- Target (low)
- 125.00
- Target (mean)
- 201.13
- Target (high)
- 220.00
Ratings (0m) 8 6 buy · 1 hold · 1 sell
- Strong buy2
- Buy4
- Hold1
- Sell0
- Strong sell1
Next earnings
Apr 30, 2021
Expected Apr 30, 2021. Consensus EPS estimate -0.25.
Financials — quick view
GWPH Revenue — quarterly 152.47M
GWPH Net income — quarterly -19.68M
GWPH EPS — quarterly -0.006
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Apr 30, 2021 | Mar 1, 2021 | -0.03 | — | — | — |
| Feb 16, 2021 | Dec 1, 2020 | -0.68 | — | — | — |
| Nov 3, 2020 | Sep 1, 2020 | -0.63 | — | — | — |
| Aug 6, 2020 | Jun 1, 2020 | -0.58 | — | — | — |
| May 11, 2020 | Mar 1, 2020 | -0.88 | — | — | — |
| Feb 25, 2020 | Dec 1, 2019 | -0.52 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 4, 2021 | Morgan Stanley | down | Overweight | Equal-Weight |
| Feb 4, 2021 | HC Wainwright & Co. | down | Buy | Neutral |
| Feb 4, 2021 | SVB Leerink | down | Outperform | Market Perform |
| Feb 3, 2021 | Needham | down | Buy | Hold |
| Aug 25, 2020 | Raymond James | init | — | Market Perform |
| Aug 7, 2020 | HC Wainwright & Co. | main | — | Buy |
News
- Ananda Pharma appoints former GW Pharmaceuticals executive Chris Tovey as adviser
- Monteverde & Associates PC and Kahn Swick & Foti Announce Proposed Class Action Settlement on Behalf of Holders of GW Pharmaceuticals PLC American Depositary Shares
- Interested in Investing in Psychedelics? Check Out This Podcast.
- Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast)
- GW Pharmaceuticals' Cannabidiol For Seizures Wins UK Approval
- Bright Minds Biosciences: A Search For The GW Pharmaceuticals Of The Psilocybin Space
- Jazz updates 2021 guidance after closing acquisition of GW Pharmaceuticals
- Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of GW Pharmaceuticals, PLC In The Southern District Of California
- A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies
- What Happened with Marijuana Stocks This Week?
Your note
Sign in to keep a note on GWPH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GUY GEOFFREY WILLIAM | Officer and Director | Sale | Nov 10, 2019 | 7,721,520 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Capital Research Global Investors | 11.85% | 3,736,209 | 431.20M | Dec 30, 2020 |
| Capital World Investors | 8.74% | 2,757,013 | 318.19M | Dec 30, 2020 |
| Janus Henderson Group PLC | 6.26% | 1,975,301 | 227.97M | Dec 30, 2020 |
| Franklin Resources, Inc. | 6.10% | 1,923,359 | 221.97M | Dec 30, 2020 |
| Canada Pension Plan Investment Board | 4.76% | 1,500,000 | 173.12M | Dec 30, 2020 |
| Morgan Stanley | 2.70% | 850,825 | 98.19M | Dec 30, 2020 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Janus Henderson Triton Fund | 2.00% | 629,433 | 72.64M | Dec 30, 2020 |
| ETF Managers Tr-EFTMG Alternative Harvest ETF | 1.97% | 621,361 | 71.71M | Dec 30, 2020 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 1.46% | 460,300 | 70.18M | Jan 30, 2021 |
| Federated Hermes Kaufmann Fund | 1.42% | 449,330 | 68.51M | Jan 30, 2021 |
| Janus Henderson Global Life Sciences Fund | 1.20% | 378,668 | 43.70M | Dec 30, 2020 |
| Brown Capital Management International Small Company Fund | 1.19% | 374,639 | 43.24M | Dec 30, 2020 |